Author name: Ben

Luxembourg government supports OrganoTherapeutics project “Drug Repurposing to combat SARS-CoV-2 brain infection”

Technology / /

OrganoTherapeutics (OT) was founded by Jens Schwamborn and Javier Jarazo in Luxembourg and focuses on the development of drugs for the treatment of Parkinson’s disease. For this purpose, OrganoTherapeutics models brain organoids in vitro, so-called “mini-brains”. With mounting evidence that SARS-CoV2 is not limited to the respiratory system but also has a negative neurological impact, […]

Luxembourg government supports OrganoTherapeutics project “Drug Repurposing to combat SARS-CoV-2 brain infection” Read More »

Jens Schwamborn Interview: Developing drugs for Parkinson’s with mini-brains

Technology / /

Jens Schwamborn and his partner Javier Jarazo founded Organo Therapeutics, an offshoot of the University of Luxembourg / Luxembourg Centre for Systems Biomedicine (LCSB). The two scientists are developing 3-D mini-brains specifically for the midbrain from stem cells of people with Parkinson’s disease. The mini-brains used are intended to help in the development and research

Jens Schwamborn Interview: Developing drugs for Parkinson’s with mini-brains Read More »